The recent stock transactions involving Derek Dubner, Chief Executive Officer and Chairman of the Board at Red Violet, Inc. (NASDAQ:RDVT), draw attention to current insider activity within the company. On June 1, 2026, Mr. Dubner sold a total of 12,000 shares of common stock. These sales represented a cumulative value of $689,160.
The weighted average prices for the distinct blocks of shares sold ranged between $57.24 and $57.62 per share. The sale was structured into two separate tranches, each comprising 6,000 shares.
- The first block saw a weighted average price of $57.62 per share, with individual transaction prices observed between $57.45 and $58.07.
- The second block was sold at a weighted average price of $57.24 per share, noting transaction prices ranging from $57.00 to $57.45.
These sales were conducted using shares that Mr. Dubner directly held.
Current Holdings and Future Vesting Obligations
Following the disposition of these 12,000 shares, Mr. Dubner's direct holdings in Red Violet common stock stand at 557,273 shares. This total quantity incorporates 52,853 restricted stock units (RSUs). The composition of these RSUs reveals several key vesting schedules:
- 13,333 units were granted on November 30, 2023, and are scheduled to vest on December 1, 2026.
- 21,000 units were granted on November 4, 2024, and will vest in two equal installments, occurring on both November 1, 2026, and November 1, 2027.
- 18,520 units were granted on December 19, 2025, with vesting scheduled across three equal installments on December 1, 2026, December 1, 2027, and December 1, 2028.
It is important to note that all RSU vestings are contingent upon accelerated vesting under specific circumstances.
Financial Context and Market Performance
From a financial standpoint, Red Violet maintains a robust position. The company reports an impressive gross profit margin of 84% and, critically, its balance sheet indicates that it holds more cash than debt. Furthermore, the firm reported exceptional results for the first quarter of 2026.
For Q1 2026, Red Violet announced an earnings per share (EPS) of $0.46. This figure exceeded the analyst anticipation of $0.33. Revenue also showed strength, reaching $25.8 million, which surpassed the projected forecast of $25.17 million. These performance metrics underscore the company's ability to outperform prevailing market expectations.
Despite these positive financial developments, current valuation indicators warrant attention. According to InvestingPro analysis, RDVT is currently assessed as being overvalued relative to its Fair Value, reflected by a P/E ratio of 59.42. The stock has also experienced significant upward momentum, surging 17% over the last week and trading near its 52-week high valuation of $64.14.
Market Overview
On the day of reporting, Red Violet traded at $58.40 after hours, reflecting a decline of -0.90 (-1.52%). The stock's recent performance data points to volatility and strong investor interest following its positive quarterly reports.